- Home
- »
- Healthcare IT
- »
-
Healthcare Data Monetization Market Size Report 2026-2033GVR Report cover
Healthcare Data Monetization Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product Type (Data Subscription, Insights-as-a-Service, Models/Decision Engines), By Data Source, By Application, By End Use, By Region, And Segment Forecasts
Market Size, 2025
$2.0BMarket Estimate, 2026
$2.1BMarket Forecast, 2033
$3.7BCAGR, 2026–2033
8.2%Healthcare Data Monetization Market Summary
The global healthcare data monetization market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.7 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 51.8% in 2025. This growth is attributed to the widespread adoption of Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Hospital Information Systems (HIS), Laboratory Information Systems (LIS), and digital imaging platforms, which has resulted in an exponential increase in structured and unstructured healthcare data.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By product type: The data subscription segment held the largest market share of 43.9% in 2025.
- By data source: The EHR/EMR data segment dominated the market with a revenue share of 28.0% in 2025.
- By application: The safety, adherence & HEOR segment held the largest market share of 24.9% in 2025.
- By end use: The pharmaceutical companies segment dominated the market with a revenue share of 27.3% in 2025.
Regional Highlights
- Largest regional market: North America (51.8% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
- By country: The U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 2.0 Billion
- Estimated market size in 2026: USD 2.1 Billion
- Projected market size by 2033: USD 3.7 Billion
- CAGR (2026-2033): 8.2%
Prism AI by Grand View Research Free to tryAsk a question about the healthcare data monetization market✓Every figure cited from GVR research Prefer the report? Download free sample →
To learn more about this report, Download Free Sample Report
Healthcare providers and payers are increasingly leveraging these datasets to generate additional revenue through analytics services, licensing, benchmarking, and value-added insights.Market Dynamics
The healthcare data monetization market is driven by due to the increasingly monetize of de-identified and longitudinal patient data, enabling healthcare organizations to generate value from clinical, claims, and operational datasets while maintaining patient privacy. The growing utilization of integrated and multi-modal data assets, including electronic health records, genomics, imaging, and wearable device data, is enhancing the quality of healthcare analytics and AI-driven insights. In addition, the rising demand for real-world evidence (RWE) and health economics and outcomes research (HEOR) is encouraging life sciences companies to invest in high-quality healthcare datasets and advanced analytics platforms to support drug development, regulatory submissions, and market access decisions.
The growing demand for real-world evidence and health economics and outcomes research (HEOR) is a significant driver of the healthcare data monetization market. Pharmaceutical companies, biotechnology firms, medical device manufacturers, and regulatory agencies increasingly rely on real-world data from electronic health records (EHRs), claims databases, registries, and patient-reported outcomes to evaluate treatment effectiveness, safety, healthcare utilization, and long-term patient outcomes. This has increased demand for organizations that provide curated datasets, analytics platforms, and RWE solutions through data subscriptions and insights-as-a-service models.
Healthcare data monetization companies such as IQVIA, Komodo Health, Flatiron Health, and HealthVerity generate revenue by transforming de-identified healthcare data into actionable evidence that supports drug development, market access, reimbursement decisions, and post-market surveillance. The increasing use of RWE and HEOR studies by life sciences companies has expanded the need for high-quality, interoperable healthcare datasets and advanced analytics platforms. For instance, in April 2025, Genomenon launched its Real-World Evidence for Precision Therapeutics solution, an AI-powered platform that mines millions of scientific publications to extract real-world data and transform it into curated real-world evidence. The platform enables pharmaceutical and biotechnology companies to accelerate clinical research, support regulatory submissions, and advance precision medicine, highlighting the growing commercial value of healthcare data.
Healthcare data monetization depends on high-quality, standardized, and interoperable data collected from multiple sources, including electronic health records, claims databases, laboratories, imaging systems, pharmacies, and wearable devices. However, differences in data formats, coding standards, and healthcare IT systems often result in fragmented, inconsistent, and incomplete datasets. These challenges reduce the reliability of analytics, AI models, and real-world evidence, making it difficult for healthcare data monetization companies to generate accurate insights and limiting the commercial value of healthcare data.
Organizations must also invest significantly in data integration, cleansing, normalization, and interoperability technologies to enable seamless data exchange across healthcare ecosystems. These additional costs and technical complexities slow the adoption of healthcare data monetization platforms, particularly among smaller healthcare providers. For instance, in July 2025, Oracle Health pledged support for the Centers for Medicare & Medicaid Services (CMS) Digital Health Ecosystem and Interoperability Framework to accelerate standardized, secure healthcare data sharing and address long-standing interoperability challenges across healthcare systems. This initiative highlights the need to improve healthcare data interoperability and standardization.
Opportunity - Expansion of AI-powered data monetization platforms and predictive analytics solutions
The expansion of AI-powered data monetization platforms and predictive analytics solutions is key opportunity for the market. Moreover, growing investment in AI-enabled data commercialization is accelerating innovation across the market. For instance, in January 2026, Datavault AI announced plans to expand its AI-driven data monetization network to more than 100 cities across the U.S. The initiative is designed to strengthen AI-powered data valuation, tokenization, and monetization capabilities, enabling organizations to generate greater value from their data assets through secure and scalable AI-driven platforms. This expansion highlights the growing demand for AI-powered healthcare data monetization.
Market Concentration & Characteristics
The degree of innovation is moderate to high. Market participants are introducing advanced AI solutions that transform clinical, claims, genomic, and real-world data into actionable insights for pharmaceutical companies, healthcare providers, and payers. For instance, in August 2025, Komodo Health launched Marmot, a healthcare-native AI analytics platform built on its Healthcare Map, enabling life sciences and healthcare organizations to generate real-time analytics and decision intelligence from de-identified patient data. The launch highlights the growing innovation in AI-powered healthcare data monetization solutions.
The level of partnerships and collaboration activities in the healthcare data monetization market is high, as organizations increasingly collaborate to improve healthcare data integration, interoperability, AI-driven analytics, and real-world evidence generation. For instance, in April 2025, Komodo Health expanded its partnership with Databricks to provide secure access to its Healthcare Map through the Databricks Marketplace and Delta Sharing, enabling life sciences organizations to analyze de-identified patient journey data using cloud-based AI and analytics platforms.
To learn more about this report, Download Free Sample Report “In today’s rapidly evolving healthcare landscape, timely access to comprehensive patient journey information and insights is essential for informed decision-making, The combination of Komodo’s Healthcare Map and the openness, scalability, and security of the Databricks Marketplace and Delta Sharing provides a powerful foundation for healthcare organizations to accelerate innovation and improve patient outcomes when and where needed.”
- Web Sun, Co-Founder and President of Komodo Health.
The impact of regulations is high, as governments continue to strengthen frameworks governing data privacy, security, interoperability, and the ethical use of healthcare data. Regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S., the General Data Protection Regulation (GDPR) in Europe, and emerging health data governance policies require organizations to ensure secure collection, de-identification, sharing, and commercialization of healthcare data. While these regulations increase compliance costs and operational complexity, they also promote trust, encourage secure data exchange, and support the adoption of standardized, interoperable healthcare data platforms, creating a foundation for sustainable healthcare data monetization.
The healthcare data monetization market is expanding as key players strengthen their presence through investments in digital health infrastructure, AI-powered analytics platforms, and healthcare data exchange solutions. Companies are expanding their healthcare data networks, forming strategic collaborations, and enhancing cloud-based platforms to improve access to real-world data, support interoperability, and meet the growing demand for data-driven healthcare insights.
Analyst Perspective
The healthcare data monetization market is expanding rapidly due to widespread healthcare digitization, a rising demand for real-world evidence, and the adoption of AI-powered analytics. Organizations are increasingly tapping into EHRs, genomics, claims, and multi-modal datasets to advance clinical research, refine decision-making, and support value-based care. In response, technology providers are building AI-enabled platforms, expanding real-world data networks, and enhancing interoperability to maximize data utility. These efforts aim to streamline data commercialization across life sciences, healthcare providers, payers, and research organizations.
Product Type Insights
Data subscription (patient-level / aggregate / licensed datasets) dominated the market with a revenue share of 43.9% in 2025. Subscription-based access provides continuous availability of high-quality datasets for drug discovery, clinical trial optimization, health economics and outcomes research, and regulatory submissions. The growing use of AI and advanced analytics has further increased demand for curated healthcare datasets, making data subscriptions the leading revenue model in the market.
Insights-as-a-service (curated analytics products) is expected to grow at the fastest CAGR over the forecast period 2026 to 2033. Organizations are looking for actionable insights rather than raw healthcare data, driving demand for AI-powered analytics, predictive models, real-world evidence, and decision support solutions delivered through cloud-based platforms. Healthcare providers, payers, and life sciences companies are adopting these services to improve clinical decision-making, optimize commercial strategies, and enhance population health management. For instance, in June 2025, HealthVerity launched HealthVerity Notes, a de-identified dataset built from more than 2.5 billion unstructured clinical EHR notes, enabling AI-ready real-world research, commercial analytics, and evidence generation. The launch reflects the growing demand for value-added healthcare insights over raw data.
Data Source Insights
EHR/EMR data dominated the healthcare data monetization market with a revenue share of 28.0% in 2025. This dominance is driven by the adoption of electronic health records and electronic medical records across hospitals, physician practices, and healthcare systems. EHR/EMR data provides comprehensive longitudinal patient information, including diagnoses, medications, laboratory results, procedures, and clinical notes, making it a critical source for real-world evidence, health economics and outcomes research, clinical trial optimization, and AI-powered healthcare analytics. The increasing adoption of interoperable EHR systems and regulatory support for health information exchange continue to strengthen the demand for monetized EHR datasets.
Integrated data assets are expected to grow at fastest CAGR during the forecast period from 2026 to 2033. Market players are increasingly combining EHRs, claims, pharmacy, laboratory, genomics, imaging, wearable, and social determinants of health (SDOH) data to generate comprehensive patient insights and improve predictive analytics. These multi-modal datasets enable more accurate clinical research, precision medicine, population health management, and commercial decision-making, driving demand from pharmaceutical companies and healthcare providers.
Application Insights
Safety, adherence & health economics and outcomes research dominated the market with a revenue share in 2025. This can be attributed to the increasing use of RWD to evaluate drug safety, treatment adherence, healthcare utilization, and long-term patient outcomes. Pharmaceutical companies, payers, and healthcare providers increasingly rely on HEOR studies to support reimbursement decisions, demonstrate product value, optimize patient outcomes, and meet regulatory requirements. The growing demand for real-world evidence and value-based healthcare continues to strengthen the adoption of monetized healthcare datasets and analytics in this segment.
Clinical research & trial enablement is expected to register the fastest growth at a CAGR of 10.3% during the forecast period. The segment is expanding due to the increasing use of de-identified healthcare data, AI-powered analytics, and real-world evidence to improve patient recruitment, optimize trial design, identify eligible study participants, and accelerate clinical research. Healthcare data monetization platforms enable life sciences companies to access high-quality longitudinal datasets that reduce trial timelines and improve research efficiency.
End Use Insights
Pharmaceutical companies dominated the healthcare data monetization market with a revenue share in 2025. The increasing use of real-world data and real-world evidence for drug discovery, clinical trial optimization, regulatory submissions, pharmacovigilance, and market access. Pharmaceutical companies rely on de-identified patient datasets, AI-powered analytics, and HEOR studies to improve clinical development, identify eligible patient populations, and support value-based healthcare decisions, making them the largest consumers of monetized healthcare data.
To learn more about this report, Download Free Sample Report Healthcare providers are expected to grow at fastest CAGR over the forecast period. Hospitals, health systems, and physician networks are increasingly adopting healthcare data monetization platforms to generate value from de-identified clinical data while improving operational efficiency, patient outcomes, and population health management. The growing adoption of AI, predictive analytics, and interoperable electronic health records is enabling providers to commercialize healthcare data through secure data-sharing initiatives and analytics services.
Regional Insights
North America dominated the market in 2025 with a revenue share of 51.8% in 2025. The region's dominance is driven by widespread adoption of electronic health records, strong healthcare IT infrastructure, and increasing use of AI-powered analytics and real-world data platforms. Favorable regulations supporting interoperability and the presence of leading healthcare data monetization companies such as IQVIA, Optum, Oracle, Komodo Health, and Datavant continue to strengthen market growth.
To learn more about this report, Download Free Sample Report U.S. Healthcare Data Monetization Market Trends
The U.S. healthcare data monetization market dominated North America in 2025 due to the widespread adoption of electronic health records, increasing investments in AI-driven healthcare analytics, and growing demand for real-world evidence. According to the Assistant Secretary for Technology Policy (ASTP), 70% of non-federal acute care hospitals engaged in all four domains of interoperable exchange (send, receive, find, and integrate) in 2023, creating a strong foundation for secure healthcare data sharing and commercialization.
Europe Healthcare Data Monetization Market Trends
The Europe healthcare data monetization market is driven by strong data privacy regulations, increasing adoption of digital health technologies, and growing demand for real-world evidence (RWE) in pharmaceutical research. Initiatives such as the European Health Data Space (EHDS) and the Data Governance Act are enhancing secure health data sharing, interoperability, and cross-border data access across member states, supporting healthcare data commercialization and innovation.
The healthcare data monetization market in the UK is driven by NHS digital transformation initiatives, increasing adoption of AI-enabled healthcare analytics, and expanding use of electronic patient records. Growing collaborations among healthcare providers, technology companies, and research institutions are improving healthcare data utilization for clinical research, operational efficiency, and value-based care.
The healthcare data monetization market in Germany is growing significantly due to government initiatives promoting healthcare digitization, increasing implementation of electronic patient records, and rising investments in AI-based healthcare analytics. The country's strong focus on interoperability and secure health data exchange is supporting the commercialization of healthcare data.
Asia Pacific Healthcare Data Monetization Market Trends
Asia Pacific is expected to grow at fastest CAGR of 10.8% over the forecast period from 2026 to 2033. Rapid healthcare digitalization, increasing investments in health IT infrastructure, expanding EHR adoption, and growing use of AI and cloud-based analytics are driving market growth. Rising pharmaceutical research activities and government initiatives supporting digital healthcare are further accelerating healthcare data monetization across the region.
The healthcare data monetization market in Japan is witnessing significant growth, driven by government-led digital health initiatives, increasing adoption of electronic medical records (EMRs), and growing demand for interoperable healthcare data platforms. Rising investments in AI, cloud computing, and precision medicine are further driving the commercialization of healthcare data for clinical research and drug development. For instance, in March 2023, Fujitsu launched a cloud-based healthcare platform in Japan that supports the HL7 FHIR standard, enabling the secure integration, sharing, and analysis of healthcare data from electronic medical records and personal health devices to advance personalized medicine and pharmaceutical research.
The healthcare data monetization market in China is growing significantly due to large-scale healthcare digitization programs, increasing AI adoption, and government initiatives such as Healthy China 2030. Growing investments in precision medicine, hospital digital transformation, and real-world data platforms are supporting the commercialization of healthcare data.
Latin America Healthcare Data Monetization Market Trends
Latin America healthcare data monetization is driven by increasing adoption of electronic health records, expanding healthcare IT investments, and growing demand for analytics solutions to improve healthcare efficiency. Government initiatives promoting digital health and value-based care are further supporting healthcare data monetization.
Middle East & Africa Healthcare Data Monetization Market Trends
The healthcare data monetization market in the Middle East & Africa is witnessing steady growth due to increasing investments in digital healthcare infrastructure, rising adoption of AI-powered healthcare analytics, and government initiatives promoting healthcare modernization. Expanding health information exchange programs and public-private collaborations are creating new opportunities for healthcare data commercialization.
Key Healthcare Data Monetization Company Insights
Key industry players are adopting various strategies, continuously innovating and introducing advanced AI-powered analytics, real-world data platforms, and interoperable healthcare data solutions to maximize the value of healthcare data assets. Companies are leveraging de-identified patient data, electronic health records, claims data, and multi-modal datasets to support clinical research, drug development, commercial decision-making, and value-based care.
Key Healthcare Data Monetization Companies:
The following key companies have been profiled for this study on the healthcare data monetization market:
-
IQVIA
-
Oracle
-
Optum
-
Veradigm
-
Komodo Health
-
Cotiviti
-
Inovalon
-
HealthVerity
-
Truveta
-
Datavant
-
Innovaccer
-
COTA
-
Flatiron Health
-
Tempus AI
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (IQVIA, Oracle Health, Optum, Veradigm, Inovalon, Cotiviti, Datavant)
- Expand healthcare data platforms, strengthen real-world data and real-world evidence capabilities, invest in AI-driven analytics, enhance interoperability, and develop strategic collaborations with life sciences companies, healthcare providers, and research organizations.
- Strong healthcare data networks, extensive longitudinal datasets, established customer base, advanced analytics capabilities, regulatory expertise, and strong financial resources to support large-scale data commercialization.
- High data acquisition and integration costs, complex regulatory compliance requirements, dependence on healthcare ecosystem partnerships, and challenges related to data standardization across sources.
Emerging Players (Komodo Health, HealthVerity, Truveta, Innovaccer, COTA, Flatiron Health, Tempus AI)
- Focus on AI-powered healthcare intelligence platforms, multi-modal data integration, precision medicine solutions, oncology and specialty-focused datasets, and innovative data-sharing models to expand healthcare data commercialization.
- Advanced AI capabilities, specialized datasets, flexible technology platforms, faster innovation cycles, and strong focus on real-world evidence and predictive analytics.
- Limited scale compared with established players, narrower therapeutic focus for some companies, dependency on healthcare data partnerships, and challenges in expanding global data networks.
Recent Developments
-
In January 2026, Datavault AI announced plans to expand its AI-driven data monetization network to more than 100 cities across the U.S. The initiative is designed to strengthen AI-powered data valuation, tokenization, and monetization capabilities, enabling organizations to generate greater value from their data assets through secure and scalable AI-driven platforms. This expansion highlights the growing demand for AI-powered healthcare data monetization.
Healthcare Data Monetization Market Report Scope
Report Attribute
Details
Market size in 2025
USD 2.0 billion
Estimated market size in 2026
USD 2.1 billion
Projected market size by 2033
USD 3.7 billion
Growth Rate
CAGR of 8.2% from 2026 to 2033
Actual data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Market Value in USD million/billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product type, data source, application, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
IQVIA; Oracle; Optum; Veradigm; Komodo Health; Cotiviti; Inovalon; HealthVerity; Truveta; Datavant; Innovaccer; COTA; Flatiron Health; Tempus AI
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Healthcare Data Monetization Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare data monetizationmarket report based on product type, data source, application, end use and regions.
-
Product Type Outlook (Revenue, USD Million, 2021 - 2033)
-
Data Subscription (patient-level / aggregate / licensed datasets)
-
Insights-as-a-Service (curated analytics products)
-
Models / Decision Engines (AI-enabled predictive products)
-
-
Data Source Outlook (Revenue, USD Million, 2021 - 2033)
-
Claims Data
-
EHR/EMR Data
-
Pharmacy Data
-
Genomics Data
-
Patient-Generated Health Data
-
Imaging Data
-
Laboratory Data
-
Integrated Data Assets
-
Others (Social Determinants of Health (SDoH) Data, Behavioral Data, Survey and Patient-Reported Data)
-
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Safety, Adherence & Health Economics and Outcomes Research (HEOR)
-
Quality Improvement & Care Gap Closure
-
Network & Operational Optimization
-
Market Access & Commercial Strategy
-
Clinical Research & Trial Enablement
-
HCP & Customer Targeting
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Pharmaceutical Companies
-
Healthcare Providers
-
Biotechnology Firms
-
Research Institutions
-
Healthcare Payers
-
Medical Device Manufacturers
-
Government Agencies
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Research Methodology
The healthcare data monetization market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each healthcare data monetization segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Product Type
Revenue Capture Definition
Data Subscription (Patient-level / Aggregate / Licensed Datasets)
Revenue generated from subscriptions and licensing of de-identified patient-level, aggregate, and longitudinal healthcare datasets, including EHR, claims, pharmacy, laboratory, and registry data provided to life sciences companies, payers, providers, and research organizations.
Insights-as-a-Service (Curated Analytics Products)
Revenue generated from subscription- or service-based healthcare analytics solutions that deliver curated insights, real-world evidence (RWE), dashboards, benchmarking, and decision support derived from healthcare data.
Models / Decision Engines (AI-enabled Predictive Products)
Revenue generated from AI-enabled predictive models, risk stratification tools, decision engines, and machine learning solutions that support clinical, operational, commercial, and population health decision-making.
Segment - Data Source
Revenue Capture Definition
Claims Data
Revenue generated from licensing and analytics of de-identified medical, pharmacy, and insurance claims data used for healthcare utilization, cost, outcomes, and reimbursement analyses.
EHR/EMR Data
Revenue generated from commercialization of de-identified electronic health record (EHR) and electronic medical record (EMR) data used for clinical research, real-world evidence, and healthcare analytics.
Pharmacy Data
Revenue generated from licensed prescription, dispensing, medication adherence, and pharmacy claims datasets used for commercial, clinical, and outcomes research.
Genomics Data
Revenue generated from genomic sequencing, molecular profiling, biomarker, and precision medicine datasets provided for drug discovery, diagnostics, and clinical research.
Patient-Generated Health Data
Revenue generated from data collected through wearable devices, mobile health applications, remote patient monitoring systems, and patient-reported health information.
Imaging Data
Revenue generated from licensing and analytics of medical imaging datasets, including radiology, pathology, CT, MRI, ultrasound, and digital imaging data.
Laboratory Data
Revenue generated from diagnostic laboratory test results, pathology reports, biomarker data, and related clinical laboratory datasets used for healthcare analytics and research.
Integrated Data Assets
Revenue generated from multi-modal datasets that combine EHR, claims, pharmacy, laboratory, genomics, imaging, and other healthcare data into unified patient-level data assets.
Others (Social Determinants of Health (SDoH) Data, Behavioral Data, Survey and Patient-Reported Data)
Revenue generated from commercialization of SDoH, behavioral, survey, patient-reported outcomes (PROs), and other complementary healthcare datasets that enhance clinical and commercial analytics.
Segment - Application
Revenue Capture Definition
Safety, Adherence & Health Economics and Outcomes Research (HEOR)
Revenue generated from healthcare data solutions supporting pharmacovigilance, medication adherence analysis, health economics, outcomes research, reimbursement, and real-world evidence generation.
Quality Improvement & Care Gap Closure
Revenue generated from analytics platforms that identify care gaps, monitor quality metrics, support clinical performance improvement, and optimize patient outcomes.
Network & Operational Optimization
Revenue generated from data analytics solutions used to improve healthcare operations, provider network performance, capacity planning, resource utilization, and workflow optimization.
Market Access & Commercial Strategy
Revenue generated from healthcare data products that support pricing, reimbursement, market access, commercial planning, patient identification, and brand performance analysis.
Clinical Research & Trial Enablement
Revenue generated from healthcare datasets and analytics solutions used for patient recruitment, protocol optimization, site selection, clinical trial design, and real-world evidence studies.
HCP & Customer Targeting
Revenue generated from physician intelligence, customer segmentation, engagement analytics, and targeting solutions that support pharmaceutical and medical device commercialization.
Others
Revenue generated from healthcare data monetization solutions supporting public health surveillance, regulatory reporting, fraud detection, and other specialized healthcare applications.
Segment - End-use
Revenue Capture Definition
Pharmaceutical Companies
Revenue generated from healthcare data monetization solutions used by pharmaceutical companies for drug discovery, clinical development, HEOR, market access, pharmacovigilance, and commercialization.
Healthcare Providers
Revenue generated from healthcare providers utilizing healthcare data platforms for clinical decision support, operational improvement, quality reporting, and secure healthcare data commercialization.
Biotechnology Firms
Revenue generated from biotechnology companies using healthcare data for biomarker discovery, precision medicine, clinical research, and therapeutic development.
Research Institutions
Revenue generated from academic and research organizations accessing healthcare datasets and analytics platforms for clinical, epidemiological, and translational research.
Healthcare Payers
Revenue generated from payers using healthcare data solutions for claims analytics, fraud detection, population health management, risk adjustment, and value-based care initiatives.
Medical Device Manufacturers
Revenue generated from medical device companies utilizing healthcare data for post-market surveillance, product performance evaluation, regulatory compliance, and commercial strategy.
Government Agencies
Revenue generated from government organizations adopting healthcare data platforms for public health monitoring, policy development, healthcare planning, and regulatory oversight.
Others
Revenue generated from healthcare consulting firms, contract research organizations (CROs), employers, digital health companies, and other organizations utilizing healthcare data monetization solutions.
Estimation Model
To learn more about this report, Download Free Sample Report Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Pricing Benchmarks and ACV Analysis
Analysis of average contract value (ACV) ranges and pricing benchmarks across healthcare data monetization solutions, segmented by buyer type and product offerings, including data subscriptions, insights-as-a-service, and AI-enabled decision engines.
Helps evaluate pricing strategies, understand buyer spending patterns, benchmark contract values, and identify revenue optimization opportunities across different customer segments.
Competitive Positioning Analysis & Market Share Analysis
Comprehensive assessment of key healthcare data monetization players covering estimated market share, product portfolio benchmarking, data assets, service offerings, strategic initiatives, partnerships, mergers & acquisitions, and competitive positioning
Enables benchmarking of market leaders and emerging players, identifies competitive gaps, and supports strategic planning, partnership decisions, and market expansion strategies.
Buyer Demand & WTP Analysis
Analysis of buyer segments, product preferences, willingness-to-pay drivers, adoption trends, and demand ranking across pharmaceutical companies, healthcare providers, payers, and other healthcare entities.
Helps identify high-value customer segments, optimize pricing strategies, and prioritize market opportunities.
Frequently Asked Questions About This Report
The data subscription segment held the largest market share of 43.9% in 2025.
The EHR/EMR data segment dominated the market with a revenue share of 28.0% in 2025.
The safety, adherence & HEOR segment held the largest market share of 24.9% in 2025.
Asia Pacific is anticipated to register the fastest growth rate.
The global healthcare data monetization solutions market size was valued at USD 2.0 billion in 2025 and is estimated at USD 2.1 billion for 2026.
The global healthcare data monetization solutions market is expected to grow at a CAGR of 8.2% from 2026 to 2033, reaching USD 3.7 billion by 2033.
North America has dominated the healthcare data monetization solutions market and held the largest revenue share of 51.8% in 2025 owing to its well-established and technologically advanced healthcare ecosystem.
Some key players operating in the healthcare data monetization solutions market include IQVIA, Oracle, Optum, Veradigm, Komodo Health, Cotiviti, Inovalon, HealthVerity, Truveta, Datavant, Innovaccer, COTA, Flatiron Health, Tempus AI.
The widespread adoption of Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Hospital Information Systems (HIS), Laboratory Information Systems (LIS), and digital imaging platforms has led to an exponential increase in both structured and unstructured healthcare data.
About the Author(s)
Healthcare IT Research Team
Healthcare · Healthcare ITThis report was authored by the healthcare it research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the healthcare it segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
